Opella has received approval to make Cialis available without a [...]

reacta-mhra-licence-analytical-testing Reacta Healthcare has received an extension to its Manufacturer’s [...]

CONNECTA Therapeutics has started a Phase 2a clinical trial of [...]

The National Institute for Health and Care Excellence (NICE) has [...]

The Scottish Medicines Consortium (SMC) has accepted TALVEY (talquetamab) for [...]

AstraZeneca is presenting a broad package of new clinical and [...]

CuraCell TX has reported new findings supporting its personalised tumour-infiltrating [...]

The World Bronchiectasis Conference (WBC) will return to Hannover, Germany, [...]

Evogene has reported positive Phase 1 data for microbiome-based therapy [...]

Phase 3 data presented at ASCO 2026 suggest a PSMA-targeted [...]